206 related articles for article (PubMed ID: 35761398)
1. Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells.
Mondal A; Roberge J; Gilleran J; Peng Y; Jia D; Akel M; Patel Y; Zoltowski H; Doraiswamy A; Langenfeld J
Cell Commun Signal; 2022 Jun; 20(1):99. PubMed ID: 35761398
[TBL] [Abstract][Full Text] [Related]
2. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans.
Vora M; Mondal A; Jia D; Gaddipati P; Akel M; Gilleran J; Roberge J; Rongo C; Langenfeld J
Cell Biosci; 2022 May; 12(1):76. PubMed ID: 35641992
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
[TBL] [Abstract][Full Text] [Related]
6. IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells.
Antonia RJ; Baldwin AS
Sci Signal; 2018 Jul; 11(538):. PubMed ID: 29991651
[TBL] [Abstract][Full Text] [Related]
7. Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells.
Mondal A; Jia D; Bhatt V; Akel M; Roberge J; Guo JY; Langenfeld J
Sci Rep; 2022 Jul; 12(1):13135. PubMed ID: 35908087
[TBL] [Abstract][Full Text] [Related]
8. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.
Ma L; Niknejad N; Gorn-Hondermann I; Dayekh K; Dimitroulakos J
PLoS One; 2012; 7(9):e46055. PubMed ID: 23029387
[TBL] [Abstract][Full Text] [Related]
10. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-induced mucosal cell death in human gastric cells: role of a caspase-independent mechanism.
Leung AM; Redlak MJ; Miller TA
Dig Dis Sci; 2009 Jan; 54(1):28-35. PubMed ID: 18612824
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
13. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury.
Seth R; Yang C; Kaushal V; Shah SV; Kaushal GP
J Biol Chem; 2005 Sep; 280(35):31230-9. PubMed ID: 15983031
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor coactivator-interacting protein (SIP) inhibits caspase-independent apoptosis by preventing apoptosis-inducing factor (AIF) from being released from mitochondria.
Wang D; Liang J; Zhang Y; Gui B; Wang F; Yi X; Sun L; Yao Z; Shang Y
J Biol Chem; 2012 Apr; 287(16):12612-21. PubMed ID: 22371500
[TBL] [Abstract][Full Text] [Related]
17. Bid-induced release of AIF from mitochondria causes immediate neuronal cell death.
Landshamer S; Hoehn M; Barth N; Duvezin-Caubet S; Schwake G; Tobaben S; Kazhdan I; Becattini B; Zahler S; Vollmar A; Pellecchia M; Reichert A; Plesnila N; Wagner E; Culmsee C
Cell Death Differ; 2008 Oct; 15(10):1553-63. PubMed ID: 18535584
[TBL] [Abstract][Full Text] [Related]
18. Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis.
Liu L; Xing D; Chen WR
Int J Cancer; 2009 Dec; 125(12):2757-66. PubMed ID: 19705411
[TBL] [Abstract][Full Text] [Related]
19. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
[TBL] [Abstract][Full Text] [Related]
20. Caspase-independent cell death mediated by apoptosis-inducing factor (AIF) nuclear translocation is involved in ionizing radiation induced HepG2 cell death.
Sun H; Yang S; Li J; Zhang Y; Gao D; Zhao S
Biochem Biophys Res Commun; 2016 Mar; 472(1):137-43. PubMed ID: 26920061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
